PROGRAMME 2025

Racing Against Resistance: The Future of Antimicrobials

Chair: Stephan Harbarth, Geneva

08:30

Opening of Registration Desk

09:00 

Welcome addresses:
Martin Traber, SGPM, Rudolf Blankart, Swiss RTA
Carlos Quinto MPH, Member of the Board of Directors of FMH

 INTRODUCTION

SESSION I: The Global Health Threat

09:30-10:10      
Are we running out of antibiotics?
Silvio Brugger, University Hospital Zurich

10:10-10:30      
The negative impact of AMR on cancer care and treatment outcomes
Shalini Jayasekar Zürn, Union for International Cancer Control (UICC)

10:30-11:00      
Coffee Break

Session II: Antimicrobial Resistance (AMR) and Use Monitoring

11:00-11:15      
AMR surveillance and antibiotic use monitoring in Switzerland
Catherine Plüss, University of Bern, ANRESIS

11:15-11:30      
Monitoring the use of antibiotics in Switzerland
Sabrina Stollberg, Helsana, Zurich

SESSION III: Innovation Challenges in Antibiotic Research and Development (R&D)

11:30-12:00      
Interdisciplinary collaboration bridging academia, industry, and policymakers to overcome funding gaps and accelerate translational research
Henni-Karoliina Ropponen, AMR Action Fund

12:00-12:30      
From basic research to accelerating product innovation
Christoph Dehio, University of Basel  

12:30-13:30      
Lunch

13:30-14:00      

Translational challenges in clinical development
Caterina Bissantz, F. Hoffmann-La Roche, Basel

14:00-14:30      

Regulatory challenges presented by innovative clinical development strategies
Rolf Kaiser, Swissmedic, Bern

14:30-15:00      
Coffee Break

Session IV: Fostering Availability of and Access to Antibiotics

15:00-15:30      
Innovative market incentives to stimulate antibiotic R&D and availability of new antibiotics
Chantal Morel, University of Bern

15:30-16:00      
Strategy on antibiotic resistance Switzerland (STAR)                           
Simon Gottwalt, Federal Office of Public Health, Bern 

Session IV: Podium:  New Approaches to Address Antimicrobial Resistance

16:00-17:00      

Moderator: Stephan Harbarth
Chantal Morel, Uni Bern
Simon Gottwalt, Federal Office of Public Health
Rolf Kaiser, Swissmedic
Christoph Dehio, Uni Basel
Caterina Bissantz, F. Hoffmann-La Roche
Henni-Karoliina Ropponen, AMR Action Fund 

17:00                 
Résumé by SGPM President